Loading Page
Dr. Caitlin K. Gribbin, MD is a medical oncologist in New York, NY specializing in medical oncology, physician, oncology (cancer care) and hematology (blood disorders). She graduated from Weill Cornell Medical College in 2019 and has 7 years of experience. Dr. Caitlin K. Gribbin, MD is affiliated with NewYork-Presbyterian, Weill Cornell Medicine and Bone Marrow Transplant and Cell Therapy Program.
Dr. Caitlin K. Gribbin, MD graduated from Weill Cornell Medical College in 2019. She is certified by the American Board of Internal Medicine (Hematology).
Medical School: Weill Cornell Medical College (2019)
Board Certification: American Board of Internal Medicine (Hematology)
Dr. Caitlin K. Gribbin, MD appears to accept the following insurance providers: GHI, Health Insurance Plan of NY (HIP), EmblemHealth, WellCare, Healthspring, AETNA, Quality Health Management (QHM), UnitedHealthcare, United Healthcare, Oxford Health Plans, CIGNA, Local 1199, Fidelis Care, Molina Healthcare, Healthfirst, Anthem Blue Cross Blue Shield, Aetna - NYP, VNSNY CHOICE, Rockefeller University/Luminare, VNS Health, WorldWide Medical, United Healthcare Community Plan (AmeriChoice), Aetna Medicare, United Healthcare Medicare, Medicare Advantage, GHI CBP, United Healthcare Empire Plan, Medicare, Medicaid, Aetna PPO, Aetna HMO, Aetna-NYP EPO/POS, Aetna Weill Cornell Employee Managed Care Plan, Oxford Health Plans Liberty, Oxford Health Plans Freedom, VNSNY CHOICE Medicare, Aetna Weill Cornell Employee PPO Plan, Rockefeller University - Trustmark, VNSNY CHOICE HMO and Oxford Health Plans Metro/Core/Charter.
According to our sources, Dr. Caitlin K. Gribbin, MD accepts the following insurance providers:
Dr. Caitlin K. Gribbin, MD does not have any reviews yet, be the first to leave a review of Dr. Caitlin K. Gribbin, MD here: Leave a Review
Caitlin Gribbin, MD, is an Assistant Professor of Medicine within the Division of Hematology and Oncology at Weill Cornell Medical Center. After earning her B.A. from Cornell University, Dr. Gribbin received her Medical Degree as well as Masters in Science from Weill Cornell Medical College. She completed her Internship and Residency as well as subsequent Fellowship training in Hematology and Oncology within the Medical Research Track at Weill Cornell Medicine/NewYork-Presbyterian Hospital. As a faculty member at Weill Cornell, Dr. Gribbin specializes in treating patients with lymphoma using cellular therapies, including chimeric antigen receptor (CAR) T cell therapy. She is simultaneously focused on leading clinical and translational research studies aimed at improving lymphoma treatments by bringing novel scientific discoveries to patients. Dr. Gribbin has co-authored numerous publications and presentations at national and international meetings and has received several research grants, including the American Society of Clinical Oncology (ASCO) Young Investigator Award, the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program Award, and the Burroughs Wellcome Fund Award.
